LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Acquired by First Eagle Investment Management LLC

First Eagle Investment Management LLC grew its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST) by 182.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 785,666 shares of the company’s stock after buying an additional 507,826 shares during the period. First Eagle Investment Management LLC’s holdings in LifeStance Health Group were worth $5,790,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. AlphaQuest LLC acquired a new stake in shares of LifeStance Health Group in the fourth quarter valued at about $340,000. Keybank National Association OH raised its position in shares of LifeStance Health Group by 86.4% in the fourth quarter. Keybank National Association OH now owns 56,974 shares of the company’s stock valued at $420,000 after buying an additional 26,412 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of LifeStance Health Group by 0.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,113,499 shares of the company’s stock valued at $8,206,000 after buying an additional 9,046 shares during the last quarter. Versor Investments LP acquired a new stake in shares of LifeStance Health Group in the fourth quarter valued at about $131,000. Finally, Bank of New York Mellon Corp raised its position in shares of LifeStance Health Group by 4.0% in the fourth quarter. Bank of New York Mellon Corp now owns 400,816 shares of the company’s stock valued at $2,954,000 after buying an additional 15,365 shares during the last quarter. 85.50% of the stock is currently owned by institutional investors and hedge funds.

LifeStance Health Group Trading Down 1.0 %

Shares of LFST opened at $6.92 on Friday. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $8.61. The firm has a 50-day moving average price of $7.80 and a 200 day moving average price of $7.34. The firm has a market capitalization of $2.66 billion, a P/E ratio of -26.62 and a beta of 1.27.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on LFST. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. The Goldman Sachs Group raised shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price objective for the company in a report on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $8.63.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.